LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Stem Cell Researchers Awarded $20 Million
Spine

Stem Cell Researchers Awarded $20 Million

August 20, 2012 1 min read Premium comments

Advertisement

Stem Cell Researchers Awarded $20 Million
Source: Wikimedia Commons and selbstfotografiert
Secondary

A husband and wife team of stem cell researchers, at the University of California, Irvine (UCI), along with a private company, have been awarded $20 million of a $150 million grant authorized by the California Institute for Regenerative Medicine. The couple, Aileen Anderson and Brian Cummings and the company, StemCells, Inc. of Newark, California, hope to begin human testing of a treatment for spinal-cord injuries in the neck region. The treatment involves injecting human neural stem cells into the neck area.

According to a July 27 report in the Orange County Register, the cells, which are capable of transforming themselves based on cues from the body, could migrate to the injured area and repair the protective sheaths, known as myelin, around nerve cells. If the treatment works as expected, it would restore movement and body control for patients with debilitating injuries.

The treatment has the potential to allow the paralyzed to walk again. That is what Anderson, in her “wildest dreams” said she would like to see take place in a clinical trial. “But, ” she says, “what you’re likely going to see for any spinal cord injury is much more incremental improvement in function.”

Anderson and Cummings are among a group of stem-cell scientists at UCI’s Sue & Bill Gross Stem Cell Research Center which has already had stem cell successes. A treatment it developed for chronic spinal cord injury, along with StemCells Inc., is now being tested on patients in Switzerland and was recently shown to be safe for the first group of patients to receive it.

StemCells Inc. grows the human neural stem cells from donated brain tissue of surgically aborted fetuses. The company has had another recent success involving UCI researchers. The company restored memory and brain function in mice bred to model the effects of Alzheimer’s disease. That achievement could eventually be translated into treatments for humans with the disease.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy